AUM Biosciences shares why it is betting on Asia and how it will achieve its vision in feature article on Scrip Pharma Intelligence

AUM is going to change the cancer treatment narrative from a drug development perspective and for patients. For more information on how why we are betting on Asia and how we will achieve our Asia-to-global vision of innovative and affordable drugs for Asians that can be taken global, read our feature here